Skip to main content
21 November 2024
Last updated:
Monday 18 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Vaccine
Vaccine
A good beginning in the perilous biotech business
Read more
Transgene in vanguard of oncolytic virus therapy
Read more
Intercell invests in antibody technology
Read more
Vaccines are an underestimated growth platform
Read more
The quest for a universal flu vaccine
Read more
Pagination
Previous page
‹‹
Page 4
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form